Human brain clearance imaging: Pathways taken by magnetic resonance imaging contrast agents after administration in cerebrospinal fluid and blood
NMR in Biomedicine · 2024-09 · 37 (9)
DOI: 10.1002/nbm.5159 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift NMR in Biomedicine, online erschienen am 18.04.2024. Verfasst von Matthias J P van Osch und 15 weiteren Autor:innen. Beteiligte Einrichtung: C. J. Gorter MRI Center, Department of Radiology, Leiden University Medical Center (LUMC), Leiden, The Netherlands. Hauptthemen laut MEDLINE: Contrast Media, Magnetic Resonance Imaging, Brain. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Norges Forskningsråd, Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Vetenskapsrådet.
Abstract (Originalsprache)
Over the last decade, it has become evident that cerebrospinal fluid (CSF) plays a pivotal role in brain solute clearance through perivascular pathways and interactions between the brain and meningeal lymphatic vessels. Whereas most of this fundamental knowledge was gained from rodent models, human brain clearance imaging has provided important insights into the human system and highlighted the existence of important interspecies differences. Current gold standard techniques for human brain clearance imaging involve the injection of gadolinium‐based contrast agents and monitoring their distribution and clearance over a period from a few hours up to 2 days. With both intrathecal and intravenous injections being used, which each have their own specific routes of distribution and thus clearance of contrast agent, a clear understanding of the kinetics associated with both approaches, and especially the differences between them, is needed to properly interpret the results. Because it is known that intrathecally injected contrast agent reaches the blood, albeit in small concentrations, and that similarly some of the intravenously injected agent can be detected in CSF, both pathways are connected and will, in theory, reach the same compartments. However, because of clear differences in relative enhancement patterns, both injection approaches will result in varying sensitivities for assessment of different subparts of the brain clearance system. In this opinion review article, the “EU Joint Programme – Neurodegenerative Disease Research (JPND)” consortium on human brain clearance imaging provides an overview of contrast agent pharmacokinetics in vivo following intrathecal and intravenous injections and what typical concentrations and concentration–time curves should be expected. This can be the basis for optimizing and interpreting contrast‐enhanced MRI for brain clearance imaging. Furthermore, this can shed light on how molecules may exchange between blood, brain, and CSF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- C. J. Gorter MRI Center, Department of Radiology, Leiden University Medical Center (LUMC), Leiden, The Netherlands.
- Department of Radiation Sciences, Radiation Physics, Biomedical Engineering, Umeå University, Umeå, Sweden.
- Department of Applied Physics and Electronics, Umeå University, Umeå, Sweden.
- Umeå Center for Functional Brain Imaging, Umeå University, Umeå, Sweden.
- Department of Neuroradiology, University Medical Center Bonn, Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany.
- German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
ORCID-Profile: Matthias J P van Osch, Anders Wåhlin, Ingrid Mossige, Lydiane Hirschler, Anders Eklund, Klara Mogensen, Ryszard Gomolka, Alexander Radbruch, Sara Qvarlander, Andreas Decker, Maiken Nedergaard, Yuki Mori, Per Kristian Eide, Katerina Deike, Geir Ringstad
Förderung
- Norges Forskningsråd
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- Vetenskapsrådet
- EU Joint Programme - Neurodegenerative Disease Research
- Alzheimer Nederland
- Swedish Foundation for Strategic Research
- Stiftelsen för Strategisk Forskning
Zitieren
APA
van Osch, M. J. P., Wåhlin, A., Scheyhing, P., Mossige, I., Hirschler, L., Eklund, A., Mogensen, K., Gomolka, R., Radbruch, A., Qvarlander, S., Decker, A., Nedergaard, M., Mori, Y., Eide, P. K., Deike, K., & Ringstad, G. (2024). Human brain clearance imaging: Pathways taken by magnetic resonance imaging contrast agents after administration in cerebrospinal fluid and blood. NMR in Biomedicine, 37(9). https://doi.org/10.1002/nbm.5159
Vancouver
van Osch MJP, Wåhlin A, Scheyhing P, Mossige I, Hirschler L, Eklund A, et al. Human brain clearance imaging: Pathways taken by magnetic resonance imaging contrast agents after administration in cerebrospinal fluid and blood. NMR in Biomedicine. 2024;37(9). doi:10.1002/nbm.5159
BibTeX
@article{vanOsch2024,
author = {van Osch, Matthias J P and Wåhlin, Anders and Scheyhing, Paul and Mossige, Ingrid and Hirschler, Lydiane and Eklund, Anders and Mogensen, Klara and Gomolka, Ryszard and Radbruch, Alexander and Qvarlander, Sara and Decker, Andreas and Nedergaard, Maiken and Mori, Yuki and Eide, Per Kristian and Deike, Katerina and Ringstad, Geir},
title = {Human brain clearance imaging: Pathways taken by magnetic resonance imaging contrast agents after administration in cerebrospinal fluid and blood},
journal = {NMR in Biomedicine},
year = {2024},
volume = {37},
number = {9},
doi = {10.1002/nbm.5159}
}
EUVIMED